Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06703567

IMproving PAtient UndeRstanding of GEP TEst Results: Phase 4

Led by European Institute of Oncology · Updated on 2024-12-10

82

Participants Needed

1

Research Sites

64 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The primary aim of the study is to determine if provision of a patient information film about Oncotype DX improves patients' knowledge and understanding about Gene Expression Profiling (GEP) test and risk of recurrence results in early breast cancer (EBC) patients, identified by their clinical teams as potentially benefiting from having their tumor samples sent for GEP analysis.

CONDITIONS

Official Title

IMproving PAtient UndeRstanding of GEP TEst Results: Phase 4

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • First presentation of early stage breast cancer with all known disease surgically removed
  • Estrogen Receptor (ER) positive and Human Epidermal growth factor Receptor 2 (HER-2) negative
  • No clear decision on whether chemotherapy should be given as adjunct based on current prognostic criteria
  • Consented to GEP testing
  • Able to give full informed consent to IMPARTER study
  • Good comprehension of the Italian language
  • Access to internet connection and devices (e.g. smart phone, tablet, laptop or desktop computer)
Not Eligible

You will not qualify if you...

  • Other breast cancer diagnosis (e.g. Ductal carcinoma in situ, Metastatic)
  • Unable to give fully informed consent
  • Under 18 years of age
  • Unable to understand and speak Italian
  • No access to internet connection or devices

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

European Institute of Oncology

Milan, Italy, 20141

Actively Recruiting

Loading map...

Research Team

G

Gabriella Pravettoni, MD

CONTACT

M

Mara Negri

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here